Discovery of a Novel Class of Orally Active Antifungal β-1,3- d -Glucan Synthase Inhibitors
Open Access
- 1 November 2011
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 55 (11), 5099-5106
- https://doi.org/10.1128/aac.00432-11
Abstract
The echinocandins are a class of semisynthetic natural products that target β-1,3-glucan synthase (GS). Their proven clinical efficacy combined with minimal safety issues has made the echinocandins an important asset in the management of fungal infection in a variety of patient populations. However, the echinocandins are delivered only parenterally. A screen for antifungal bioactivities combined with mechanism-of-action studies identified a class of piperazinyl-pyridazinones that target GS. The compounds exhibited in vitro activity comparable, and in some cases superior, to that of the echinocandins. The compounds inhibit GS in vitro, and there was a strong correlation between enzyme inhibition and in vitro antifungal activity. In addition, like the echinocandins, the compounds caused a leakage of cytoplasmic contents from yeast and produced a morphological response in molds characteristic of GS inhibitors. Spontaneous mutants of Saccharomyces cerevisiae with reduced susceptibility to the piperazinyl-pyridazinones had substitutions in FKS1. The sites of these substitutions were distinct from those conferring resistance to echinocandins; likewise, echinocandin-resistant isolates remained susceptible to the test compounds. Finally, we present efficacy and pharmacokinetic data on an example of the piperazinyl-pyridazinone compounds that demonstrated efficacy in a murine model of Candida glabrata infection.Keywords
This publication has 42 references indexed in Scilit:
- Fluconazole Transport into Candida albicans Secretory Vesicles by the Membrane Proteins Cdr1p, Cdr2p, and Mdr1pEukaryotic Cell, 2010
- Multiple Functional Domains of the Yeast l,3-β-Glucan Synthase Subunit Fks1p Revealed by Quantitative Phenotypic Analysis of Temperature-Sensitive MutantsGenetics, 2010
- Fungal echinocandin resistanceFungal Genetics and Biology, 2010
- Correlating Echinocandin MIC and Kinetic Inhibition of fks1 Mutant Glucan Synthases for Candida albicans : Implications for Interpretive BreakpointsAntimicrobial Agents and Chemotherapy, 2009
- A Ser678Pro Substitution in Fks1p Confers Resistance to Echinocandin Drugs in Aspergillus fumigatusAntimicrobial Agents and Chemotherapy, 2007
- Resistance to echinocandin-class antifungal drugsDrug Resistance Updates, 2007
- Proteome survey reveals modularity of the yeast cell machineryNature, 2006
- Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical Candida sp. IsolatesAntimicrobial Agents and Chemotherapy, 2005
- Piperazine Propanol Derivative as a Novel Antifungal Targeting 1,3-.BETA.-D-Glucan SynthaseBiological & Pharmaceutical Bulletin, 2005
- Identification of Yeast Rho1p GTPase as a Regulatory Subunit of 1,3-β-Glucan SynthaseScience, 1996